Filter by audience:
Poster podcasts
Combination of Erenumab (Aimovig) and Onabotulinum Toxin a (BoNT-A or Botox) Is Safe and Effective
AHSAM 2020 - Poster session
Published on July 17, 2020
Efficacy and Safety of Fremanezumab in Patients with Episodic and Chronic Migraine and Inadequate Response to 2-4 Classes of Preventive Medications: Results of the Open-label Period of the Phase 3b FOCUS Study
AHSAM 2020 - Poster session
Published on July 17, 2020
Calcitonin Gene Related Peptide Monoclonal Antibodies in the Treatment of Migraine: Is There a Difference in Efficacy Between Inhibitors of the Ligand Compared to Inhibitors of the Receptor?
AHSAM 2020 - Poster session
Published on July 17, 2020
Disability Severity Category Shift with Fremanezumab Treatment: Pooled Results of 3 Randomized, Double-blind, Placebo-controlled Phase 3 Studies
AHSAM 2020 - Poster session
Published on July 23, 2020
Efficacy of Fremanezumab by Prior Number of Preventive Treatments with Inadequate Response in Patients with Episodic Migraine and Chronic Migraine: Results of the International, Multicenter Phase 3b FOCUS Study
AHSAM 2020 - Poster session
Published on July 30, 2020
Patient-identified Most Bothersome Symptom in Patients with Chronic Migraine: An Analysis of PROMISE-2
AHSAM 2020 - Poster session
Published on July 30, 2020
Efficacy of Fremanezumab in Male Patients with Migraine and Documented Inadequate Response to 2-4 Classes of Migraine Preventive Treatments: Results of the Randomized, Placebo-controlled FOCUS Study
AHSAM 2020 - Poster session
Published on August 27, 2020
Pooled Analysis of Tolerability with Fremanezumab Treatment in Patients with Episodic or Chronic Migraine and Cardiovascular Medication Use at Baseline
AHSAM 2020 - Poster session
Published on September 3, 2020
Healthcare Resource Utilization and Health-related Quality of Life in Adult Patients with Chronic Migraine: Results from the PREDICT Study
AHSAM 2020 - Poster session
Published on September 11, 2020
Depression and Migraine – a Double Whammy on Patient-reported Health
AHSAM 2020 - Poster session
Published on September 17, 2020
CGRP Monoclonal Antibodies in the Treatment of Migraine in Elderly Patients: A Single Center Experience
AHSAM 2020 - Poster session
Published on September 11, 2020
Efficacy of Inpatient Infusions for Patients with Chronic Migraine and History of Head Trauma
AHSAM 2020 - Poster session
Published on September 17, 2020
Safety of Using Onabotulinumtoxina for the Treatment of Chronic Migraine in Pregnancy
AHSAM 2020 - Poster session
Published on September 17, 2020
Erenumab Response in Highly Refractory Migraine Patients Followed at a Canadian Tertiary Headache Clinic: Preliminary Results of a Small Case Series at Six Months
AHSAM 2020 - Poster session
Published on July 23, 2020
Blood-csf Barrier Transport in Migraine Differs with Headache Frequency
AHSAM 2020 - Poster session
Published on August 27, 2020
Seeking Care, Diagnosis, and Acute Prescription for Migraine Among Those with Headache-related Disability: Results of the OVERCOME Study
AHSAM 2020 - Poster session
Published on September 11, 2020
Are People with Migraine Willing to Engage in Digitally Based Behavioral Therapies: A Look at Recruitment Statistics for a Mobile Health Study
AHSAM 2020 - Poster session
Published on October 2, 2020 | NEW
Measuring Headache Impact: Combining Pain and Disability Scores to Provide a Single Measure of Overall Headache Severity and Frequency
AHSAM 2020 - Poster session
Published on October 2, 2020 | NEW
Surveying the Patient Perspective on Headache Intake Forms: A Cohort Study
AHSAM 2020 - Poster session
Published on October 2, 2020 | NEW
Ubrogepant for the Acute Treatment of Migraine: Pooled Efficacy from ACHIEVE I and ACHIEVE II Phase 3 Trials
AHSAM 2020 - Poster session
Published on July 23, 2020
Effect of a Change in Lasmiditan Dose on Drug Efficacy and Safety: Phase 3 Study Findings
AHSAM 2020 - Poster session
Published on July 23, 2020
Eptinezumab Reduced Acute Medication Use in Patients with Chronic Migraine and Medication-overuse Headache: Subgroup Analysis of PROMISE-2
AHSAM 2020 - Poster session
Published on July 23, 2020
Patient Acceptability of a Novel Upper Nasal Delivery System for DHE – Using the Precision Olfactory Delivery Device
AHSAM 2020 - Poster session
Published on July 30, 2020
Cardiovascular Safety of Erenumab in Patients with Migraine and Aura
AHSAM 2020 - Poster session
Published on August 27, 2020
Long-term Cardiovascular Safety of Lasmiditan for the Acute Treatment of Migraine for up to One Year: Interim Results of an Open-label Phase 3 Study (GLADIATOR)
AHSAM 2020 - Poster session
Published on August 27, 2020
Safety and Tolerability of Ubrogepant Within Various Demographic and Clinical Characteristic Subgroups
AHSAM 2020 - Poster session
Published on August 27, 2020
Efficacy of Erenumab in Chronic Migraine (CM) Patients with Acute Headache Medication Overuse (MO): A Post Hoc Analysis Assessing Outcomes Using Different Definitions of Remission
AHSAM 2020 - Poster session
Published on September 3, 2020
Ubrogepant Is Effective in the Acute Treatment of Migraine with Mild Pain
AHSAM 2020 - Poster session
Published on September 3, 2020
Impact of Galcanezumab on Total Pain Burden: Findings from Phase 3 Randomized, Double-Blind, Placebo-Controlled Studies in Patients with Episodic or Chronic Migraine
AHSAM 2020 - Poster session
Published on September 11, 2020
Consistency of Effect with Galcanezumab Across Multiple Cluster Periods in Episodic Cluster Headache
AHSAM 2020 - Poster session
Published on July 17, 2020
Efficacy of Galcanezumab in Patients with Episodic Cluster Headaches and a History of Preventive Treatment Failure
AHSAM 2020 - Poster session
Published on July 23, 2020
Gastrointestinal Comorbidities Representing a Relative Contraindication to NSAID Use: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
AHSAM 2020 - Poster session
Published on July 17, 2020
Persistence to Onabotulinumtoxina versus Calcitonin Gene-related Peptide Monoclonal Antibodies (CGRP Mabs) Among Migraine Patients in a US Electronic Health Record Database
AHSAM 2020 - Poster session
Published on September 3, 2020
The Association Between Adverse Childhood Experiences and Primary Headache Disorders: A Prognostic Systematic Review and Meta-analysis
AHSAM 2020 - Poster session
Published on September 3, 2020
The Effect of Nerve Blocks on Head Pain with or Without Opioid Use
AHSAM 2020 - Poster session
Published on September 3, 2020
Electronic Health Record Documentation of Headache Presentation: Argument for Improvement in an Integrated Healthcare System in Order to Better Treatment
AHSAM 2020 - Poster session
Published on September 17, 2020
Quickest Way to 50% Less Headache Days: An Operational Research Model and Its Implementation for Chronic Migraine
AHSAM 2020 - Poster session
Published on September 17, 2020
Comparing Complementary and Integrative Health Perspectives Among VA Providers and Veteran Patients for the Treatment of Headache Disorders
AHSAM 2020 - Poster session
Published on October 2, 2020 | NEW
Observations on the Landscape of Migraine Social Media: A Twitter Longitudinal Infodemiology Study
AHSAM 2020 - Poster session
Published on October 2, 2020 | NEW
Poor Sleep Quality, Stress and Depressive Symptoms and Subsequent Headache in Patients with Episodic Migraine: A Prospective Cohort Study
AHSAM 2020 - Poster session
Published on October 2, 2020 | NEW
Development of a Text Message-based Headache Diary in Adolescents and Children
AHSAM 2020 - Poster session
Published on September 17, 2020
A 25-year Gender Trend Analysis of Authorship in Headache: The Journal of Head and Face Pain
AHSAM 2020 - Poster session
Published on September 3, 2020
Impact of Galcanezumab on Total Pain Burden in Patients with Chronic Cluster Headache: Post-hoc Analysis from a Phase 3, Randomized, Double-blind, Placebo-controlled Study
AHSAM 2020 - Poster session
Published on September 17, 2020
Migraine-specific Quality of Life Questionnaire (MSQ) Version 2.1 Score Improvement in Japanese Patients with Episodic Migraine by Galcanezumab Treatment: CGAN Japan Phase 2 Study
AHSAM 2020 - Poster session
Published on October 2, 2020 | NEW
Ubrogepant Does Not Induce Latent Sensitization in a Preclinical Model of Medication Overuse Headache
AHSAM 2020 - Poster session
Published on September 11, 2020
Low Rates of Rescue Medication Usage in Subjects Treated with a Single Dose of Rimegepant 75 Mg for the Acute Treatment of Migraine: Results from 3 Phase 3 Clinical Trials
AHSAM 2020 - Poster session
Published on July 17, 2020
Migraine Response in Patients with Migraine Receiving Eptinezumab Treatment: Consistency Throughout the PROMISE-1 and PROMISE-2 Trials
AHSAM 2020 - Poster session
Published on July 17, 2020
Safety and Tolerability of Ubrogepant for the Acute Treatment of Migraine Following Co-administration with Preventive Monoclonal Antibody Treatment
AHSAM 2020 - Poster session
Published on July 17, 2020
A Close Association of Pain Freedom with Freedom from Most Bothersome Symptom and from Migraine-related Functional Disability in Lasmiditan Studies SAMURAI and SPARTAN
AHSAM 2020 - Poster session
Published on July 17, 2020
Topiramate Is Helpful for Migraine Prevention in Adolescents: A Pediatric Headache Clinic's Experience
AHSAM 2020 - Poster session
Published on July 17, 2020
Preliminary Analysis of the Sustained Effects of a Single Low Oral Dose of Psilocybin in Migraine Headache
AHSAM 2020 - Poster session
Published on July 30, 2020
Prevalence and Impact of Cutaneous Allodynia in Migraine, Probable Migraine and Tension-type Headache: A Population-based Study in Korea
AHSAM 2020 - Poster session
Published on July 30, 2020
Analysis of Initial Non-response to Galcanezumab in Patients With Treatment- Resistant Migraine: Results From the CONQUER Trial
AHSAM 2020 - Poster session
Published on July 30, 2020
Impact of Integrating an App into the Management of Patients with Migraine in the Primary Care Setting
AHSAM 2020 - Poster session
Published on July 30, 2020
Cost-effectiveness Sequential Simulation Modeling of Fremanezumab versus Other Therapies for Migraine Prevention from Private and Public Payer Perspectives in Canada
AHSAM 2020 - Poster session
Published on September 11, 2020
Functional Connectivity in Migraineurs with Photo-, Phono-, Osmophobia: Static and Dynamic Resting-state Functional Magnetic Resonance Imaging Study
AHSAM 2020 - Poster session
Published on August 27, 2020
Acute Care: walk-in Headache Treatment Within Neurology Outpatient Clinic
AHSAM 2020 - Poster session
Published on August 27, 2020
NIH HEAL Initiative Programs to Accelerate Development of Non-addictive Therapeutics for Pain: Preclinical Screening Platform for Pain and Early Phase Pain Investigation Clinical Network
AHSAM 2020 - Poster session
Published on October 2, 2020 | NEW
Measuring Impact of Activity and Concussion on Neuropathic Pain and Cgrp Expression in Adolescent Rats
AHSAM 2020 - Poster session
Published on July 17, 2020
Exacerbation of Headache by Lifestyle Changes Common to Pregnancy: Is Pregnancy Bound to Worsen Neurological Conditions?
AHSAM 2020 - Poster session
Published on September 11, 2020
Program Development, Implementation and Outcomes of a Mindfulness Training Program for an Interdisciplinary Headache Team at an Academic Medical Center
AHSAM 2020 - Poster session
Published on September 17, 2020
Association and Effect of Sociodemographics on the Severity and Risk of Mortality in Hospital Admissions for Headache
AHSAM 2020 - Poster session
Published on July 23, 2020